Methylphenidate Transdermal
Last Updated: July 7, 2017
Status: Current
Methylphenidate Transdermal
Products Affected - Description
-
All presentations are currently available
Reason for the Shortage
-
Noven had Daytrana patches on shortage due to packaging problems.
Available Products
-
Daytrana transdermal patch, Noven
10 mg, 30 count (NDC 68968-5552-30)
15 mg, 30 count (NDC 68968-5553-30)
20 mg, 30 count (NDC 68968-5554-30)
30 mg, 30 count (NDC 68968-5555-30)
Related Shortages
| Acetaminophen and Codeine Phosphate 300 mg/30 mg Tablets | Resolved |
| Cefepime Injection | Current |
| Dexmethylphenidate Hydrochloride | Resolved |
| Flumazenil Injection | Resolved |
| Levorphanol Tablets | Resolved |
| Methylphenidate Hydrochloride Chewable Tablets | Current |
| Methylphenidate Hydrochloride Extended Release Oral Presentations | Resolved |
| Methylphenidate Hydrochloride Immediate Release Tablets | Resolved |
| Pramipexole Dihydrochloride Tablets | Resolved |
| Reserpine Oral Tablets | No Longer Available No Commercially Available Preparations |
| Rotigotine Transdermal Systems (Neupro) | Resolved |
Updated
July 7, June 12, April 4, March 8, January 10, 2017; December 5, October 11, September 27, August 1, April 18, February 3, January 13, 2016; December 2, November 18, 2015, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
